Response to a Letter to the Editor from Kanaujia et al
J Hosp Infect
.
2024 Dec 3:S0195-6701(24)00398-0.
doi: 10.1016/j.jhin.2024.09.030.
Online ahead of print.
Authors
Lia Moshkanbaryans
1
,
Vaibhav Shah
2
,
Lit Yeen Tan
3
,
Michael P Jones
4
,
Karen Vickery
5
,
Michelle Alfa
6
,
Jonathan Burdach
7
Affiliations
1
Medical Affairs, Nanosonics Ltd., Sydney, Australia.
2
Bioscience, Nanosonics Ltd., Sydney, Australia.
3
Clinical Affairs, Nanosonics Ltd., Sydney, Australia.
4
School of Psychological Sciences, Faculty of Medicine, Health & Human Sciences, Macquarie University, Sydney, Australia.
5
Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.
6
AlfaMed Consulting, Winnipeg, Manitoba, Canada.
7
Medical Affairs, Nanosonics Ltd., Sydney, Australia. Electronic address:
[email protected]
.
PMID:
39638046
DOI:
10.1016/j.jhin.2024.09.030
No abstract available
Publication types
Letter